Posted in | News

New Medical Center Under Construction in NYC Purchases Tecogen’s Efficient Gas Chiller

Tecogen® Inc. today announced the sale of a TECOCHILL® DTx 400 ton natural gas-powered chiller to a new outpatient medical center currently under construction in New York City.  The highly efficient chiller will provide reliable, cost-effective, chilled water for air conditioning the 15-story, approximately 200K square foot building.

The facility is pursuing LEED certification (Leadership in Energy and Environmental Design) and TECOCHILL's efficiency and low emissions will significantly contribute to the LEED certification point scoring system. In addition, the TECOCHILL unit features a heat-recovery option that turns 'waste heat' into hot water for domestic use.

"Being chosen to provide air conditioning for new construction of an outpatient medical center in NYC, proves once again, that Tecogen's reliable, cost-effective equipment is the right choice in large urban environments such as Manhattan," said Robert Panora, President and COO of Tecogen.

TECOCHILL units eliminate the portion of the electricity usage associated with a facility's air-conditioning load and replace it with low-cost summer natural gas. Also, punitive charges relating to monthly peak demand are proportionately reduced.

Source: http://www.tecogen.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.